http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016063298-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-424 |
| filingDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015f7b09890593017a1f1d2486e8a66b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0601d7da1c61704b76684cc52b632b7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90969a58af83eea63766b63530911cc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0b0ce2e6075f2b53f5d61fc9610b569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fbf5454138d9badf4ff545d33dc10d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e3bda53a392c77d3c25f0f6abfa5fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21ddf412eeba9617a229316684f78940 |
| publicationDate | 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2016063298-A1 |
| titleOfInvention | Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof |
| abstract | The present invention relates to new generation of triazole functionality containing 6-nitro-2,3-dihydroimidazooxazole agents for general formula I, their method of preparation and their use as drugs for treatment of tuberculosis, MDR-TB and XDR-TB either alone or in combination with other anti-tubercular agents. In general formula l, X is selected from a group (CH 2 ) n or a direct bond, where n is any number from 1-6,Y is selected from O, S or direct bond, R 1 is selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, biaryl, substituted biaryl, heterocyclic and substituted heterocyclic, wherein the substituted heterocyclic is selected from any of the following rings consisting of piperazinyl, morpholinyl, piperidyl, pyridyl, triazolyl, triazinyl, pyrimidinyl, pyridazinyl, oxazolyl, furanyl, benzofuranyl, thiophenyl, pyrrolyl, imidazoyl, thiazoyl, quinolinyl, isoquinolinyl, benzooxazolyl and benzothiazolyl and the substitution on aryl and biaryl is selected from the group consisting of F, CI, Br, I, CF 3 , OCF 3 , OR 11 , NO 2 and alkyl chain from C1 to C14, wherein R 11 is selected from the group consisting of H, alkyl, phenyl and substituted phenyl. |
| priorityDate | 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 243.